BlackRock Investment Management’s Harvard Bioscience HBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $17K | Hold |
5,697
| – | – | ﹤0.01% | 3395 |
|
|
2016
Q3 | $15K | Hold |
5,697
| – | – | ﹤0.01% | 3401 |
|
|
2016
Q2 | $16K | Sell |
5,697
-120,947
| -96% | -$340K | ﹤0.01% | 3417 |
|
|
2016
Q1 | $382K | Buy |
126,644
+1,387
| +1% | +$4.18K | ﹤0.01% | 2990 |
|
|
2015
Q4 | $435K | Buy |
125,257
+1,296
| +1% | +$4.5K | ﹤0.01% | 3039 |
|
|
2015
Q3 | $469K | Buy |
123,961
+9,166
| +8% | +$34.7K | ﹤0.01% | 3043 |
|
|
2015
Q2 | $654K | Buy |
114,795
+109,548
| +2,088% | +$624K | ﹤0.01% | 3020 |
|
|
2015
Q1 | $31K | Buy |
5,247
+6
| +0.1% | +$35 | ﹤0.01% | 3353 |
|
|
2014
Q4 | $30K | Hold |
5,241
| – | – | ﹤0.01% | 3377 |
|
|
2014
Q3 | $21K | Buy |
5,241
+223
| +4% | +$894 | ﹤0.01% | 3390 |
|
|
2014
Q2 | $23K | Sell |
5,018
-83,991
| -94% | -$385K | ﹤0.01% | 3353 |
|
|
2014
Q1 | $422K | Buy |
89,009
+3,655
| +4% | +$17.3K | ﹤0.01% | 3021 |
|
|
2013
Q4 | $401K | Sell |
85,354
-30,632
| -26% | -$144K | ﹤0.01% | 3032 |
|
|
2013
Q3 | $463K | Buy |
115,986
+1,528
| +1% | +$6.1K | ﹤0.01% | 2953 |
|
|
2013
Q2 | $408K | Buy |
+114,458
| New | +$408K | ﹤0.01% | 2954 |
|